$LKFT News

Lakefront Biotherapeutics - Sponsored ADR (LKFT) Upgraded to Buy: What Does It Mean for the Stock?

Lakefront Biotherapeutics (ENXTAM:LKFT) Stock Looks Undervalued Despite A 40% Five Year Fall

Belgian startup revives Galapagos CAR-T research

RBC Capital Upgrades Lakefront Biotherapeutics to Outperform, Raises Price Target to $45

Lakefront Biotherapeutics NV (LKFT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Lakefront Biotherapeutics: A Cash Discount With A More Credible Path To Value

Acquisition of Own Shares

Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Acquisition of Own Shares

Lakefront Receives Transparency Notification from Bank of America

Lakefront Biotherapeutics (ENXTAM:LKFT) Stock After Recent Gains Still A Recovery Opportunity?

Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer

Lakefront Biotherapeutics NV (AMS:LKFT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Lakefront Biotherapeutics NV 2026 Q1 - Results - Earnings Call Presentation

Galapagos NV (GLPG) Q1 2026 Earnings Call Transcript

Galapagos Q1 EPS US$0.25 Beats US$(1.27) Estimate, Sales US$7.589M Miss US$16.040M Estimate

Galapagos Announces Nomination of Gino Santini to its Board of Directors

Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings

Galapagos Intends To Appoint Gino Santini As Board Chair, Effective April 28

Assessing Galapagos (ENXTAM:GLPG) Valuation After Mixed Returns And A Modest Undervaluation Estimate